Jonathan N W N Barker

13PUBLICATIONS
75CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersEpidemiological modellingDermatologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

|Jul 17, 2025
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis.

Alice Smail, Nick Dand, Xinyue Liu

|May 03, 2025
Efficacy and Safety of Apremilast Over 52 Weeks in Patients with Plaque Psoriasis in High-Impact Areas and Impaired Quality of Life.

Matthias Augustin, Jonathan Barker, Curdin Conrad

|Apr 04, 2025
Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.

Kenneth B Gordon, Yayoi Tada, Milan J Anadkat

|Feb 10, 2025
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.

Kenneth B Gordon, Yayoi Tada, Milan J Anadkat

|Jan 23, 2025
Global Delphi consensus on treatment goals for generalized pustular psoriasis.

Jonathan N Barker, Emmylou Casanova, Siew Eng Choon

Pageof 3

Frequent Collaborators

6 joint publications

Christopher E M Griffiths

5 joint publications

Catherine H Smith

5 joint publications

Nick J Reynolds

4 joint publications

Nick Dand